Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
SSE:688505
Operating Margin
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
Country | CN |
Market Cap | 560.2m CNY |
Operating Margin |
12%
|
Country | JP |
Market Cap | 776 550.9T JPY |
Operating Margin |
-83%
|
Country | US |
Market Cap | 731.8B USD |
Operating Margin |
32%
|
Country | DK |
Market Cap | 4T DKK |
Operating Margin |
45%
|
Country | UK |
Market Cap | 440.4B GBP |
Operating Margin |
3%
|
Country | US |
Market Cap | 372.2B USD |
Operating Margin |
28%
|
Country | US |
Market Cap | 332.3B USD |
Operating Margin |
10%
|
Country | UK |
Market Cap | 187.7B GBP |
Operating Margin |
18%
|
Country | CH |
Market Cap | 189B CHF |
Operating Margin |
32%
|
Country | CH |
Market Cap | 182.7B CHF |
Operating Margin |
28%
|
Country | US |
Market Cap | 161.7B USD |
Operating Margin |
19%
|
Profitability Report
View the profitability report to see the full profitability analysis for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd.
See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd's most recent financial statements, the company has Operating Margin of 11.8%.